May T, Rambeck B
Ther Drug Monit. 1985;7(4):387-90. doi: 10.1097/00007691-198512000-00004.
The influence of valproate (VPA) dose, VPA preparation used, comedication (phenobarbital, phenytoin, carbamazepine) and factors such as age, weight, height, and sex on the concentration of VPA in serum was investigated. Nonlinear regression analysis showed that about 63% of the variance in the VPA morning concentrations of 259 inpatients could be explained by the following variables: dose, body weight, sex, and comedication. Age, height, and kind of preparation had no important influence on the VPA concentration. The relationship between dose and concentration of VPA is nonlinear, as the concentration does not increase proportionally with the dose but increases to a lesser extent. The serum concentration of VPA is clearly lower when the drug is given in combination with phenytoin (49.5%), carbamazepine (66.2%), or phenobarbital (76.3%) than when given alone (100%).
研究了丙戊酸盐(VPA)剂量、所用VPA制剂、合并用药(苯巴比妥、苯妥英、卡马西平)以及年龄、体重、身高和性别等因素对血清中VPA浓度的影响。非线性回归分析表明,259例住院患者VPA早晨浓度约63%的变异可由以下变量解释:剂量、体重、性别和合并用药。年龄、身高和制剂类型对VPA浓度无重要影响。VPA剂量与浓度之间的关系是非线性的,因为浓度并非与剂量成比例增加,而是增加幅度较小。当VPA与苯妥英(49.5%)、卡马西平(66.2%)或苯巴比妥(76.3%)联合使用时,其血清浓度明显低于单独使用时(100%)。